ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1491

Single-cell Analysis of Paired Skin and Blood Samples from Patients with SLE and Cutaneous Lupus Suggests CD16+ DCs Arise from Non-classical Monocytes That Enter Nonlesional Skin, Undergo Type I IFN Education, and Engage in Extensive Crosstalk with Diverse Immune and Stromal Cell Types

Allison Billi1, Feiyang Ma2, Olesya Plazyo3, Grace Hile3, Xianying Xing3, Mehrnaz Gharaee-Kermani4, Rachael Wasikowski3, Lam Tsoi3, Matteo Pellegrini2, Robert L. Modlin2, Johann Gudjonsson1 and J. Michelle Kahlenberg3, 1Department of Dermatology, University of Michigan, Ann Arbor, MI, 2University of California Los Angeles, Los Angeles, CA, 3University of Michigan, Ann Arbor, MI, 4Internal Medicine - Division of Rheumatology and Department of Dermatology, University of Michigan, Ann Arbor, MI

Meeting: ACR Convergence 2021

Keywords: Cutaneous, Gene Expression, interferon, skin, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 9, 2021

Session Title: SLE – Etiology & Pathogenesis Poster (1480–1506)

Session Type: Poster Session D

Session Time: 8:30AM-10:30AM

Background/Purpose: Cutaneous lupus erythematosus (CLE) is an incompletely understood autoimmune disease that can occur in isolation or in the context of SLE. CLE is often disfiguring, and no FDA-approved therapies exist. Further, evidence suggests skin inflammation in CLE can provoke systemic autoimmune disease, including precipitating nephritis. Thus, understanding CLE pathogenesis has great potential to alleviate lupus morbidity and even mortality.

Methods: We used single-cell RNA sequencing (scRNA-seq) to investigate cellular transcriptomes in lesional skin, sun-protected nonlesional skin, and peripheral blood mononuclear cell (PBMC) samples from 7 CLE patients. 6 of 7 patients met ACR criteria for SLE. Data were analyzed in combination with control skin biopsies taken from 14 healthy patients and PBMCs from 4 healthy donors using Seurat. Keratinocytes (KCs), melanocytes, eccrine gland cells, endothelial cells, fibroblasts (FBs), smooth muscle cells, nerve cells, T cells, myeloid cells, and mast cells were identified. KCs, FBs, T cells, and myeloid cells were sub-clustered and cell subsets annotated. Cytokine module scores were calculated for KCs and FBs using signature genes induced upon treatment of KCs and FBs with panels of cytokines. Cell-cell communication was examined using CellPhoneDB to perform ligand-receptor analysis for select cell subsets. To further investigate cellular interactions, spatial sequencing was performed, and cell signatures derived from scRNA-seq were used to identify the proximity of different cell types in lesional skin from a patient with DLE. Finally, pseudotime analysis was performed on cells bridging the connection between circulating and skin-resident myeloid cells.

Results: Both lesional and nonlesional SLE/CLE KCs showed very strong type I IFN signature scores (Fig. 1). Lesional and nonlesional SLE/CLE skin exhibited dramatic shifts in cell-cell crosstalk (Fig. 2A-C); CD16+ DCs were very enriched in CLE lesions relative to control and were among the most active communications both as expressers of ligands (horizontal) and receptors (vertical) even in nonlesional SLE/CLE skin (Fig. 2D). Spatial transcriptomics demonstrated CD16+ DCs localizing most prominently in the superficial dermis, enabling interaction with KCs. Sub-clustering of paired circulating and skin myeloid cells revealed CD16+ DCs may arise from non-classical monocytes, with discrete shifts in myeloid cell transcriptional states, including a robust IFN education in the skin, detectable across this transition (Fig. 3).

Conclusion: Nonlesional skin of patients with SLE and CLE exists in a type I IFN-rich, “prelesional” state. This affects gene transcription in all major cell types present in skin and dramatically alters cell-cell communication. Non-classical monocytes may infiltrate this environment to become CD16+ DCs that engage in crosstalk with diverse cell types as one of the earliest steps in the evolution of CLE lesions.

Fig. 1. KC sub-clustering. A. KC subsets. B. KCs colored by origin; healthy (H), nonlesional lupus (N), lesional lupus (L) skin. C. KCs colored by IFNα cytokine module scores.

Fig. 2. Number of predicted ligand-receptor interactions in skin. Red, more interactions. ML, myeloid cell. MLNC, melanocyte. SMC, smooth muscle cell. TC, T cell. EC, endothelial cell. ECG, eccrine gland. A. Control skin. B. Nonlesional lupus skin. C. Lesional lupus skin. D. Receptor-ligand interactions of detailed cell subsets in the skin.

Fig. 3. CD16+ DCs may arise from circulating non-classical monocytes (ncMo). A. Myeloid cells from paired skin and PBMC samples colored by subset. Mono, classical monocyte. B. Colored by origin. HP, healthy PBMC. LP, lupus PBMC. C. Pseudotime projection of the transition of ncMo to CD16+ DC. D. Gene markers cluster into five expression patterns across pseudotime.


Disclosures: A. Billi, None; F. Ma, None; O. Plazyo, None; G. Hile, None; X. Xing, None; M. Gharaee-Kermani, None; R. Wasikowski, None; L. Tsoi, None; M. Pellegrini, None; R. Modlin, None; J. Gudjonsson, Almirall, 5, Eli Lilly, 5, BMS, 5; J. Kahlenberg, astrazeneca, 1, Janssen, 5, Bristol Myers Squibb, 1, 5, q32 Bio, 5, Ventus Therapeutics, 2, Eli Lilly, 1, GlaxoSmithKlein, 1.

To cite this abstract in AMA style:

Billi A, Ma F, Plazyo O, Hile G, Xing X, Gharaee-Kermani M, Wasikowski R, Tsoi L, Pellegrini M, Modlin R, Gudjonsson J, Kahlenberg J. Single-cell Analysis of Paired Skin and Blood Samples from Patients with SLE and Cutaneous Lupus Suggests CD16+ DCs Arise from Non-classical Monocytes That Enter Nonlesional Skin, Undergo Type I IFN Education, and Engage in Extensive Crosstalk with Diverse Immune and Stromal Cell Types [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/single-cell-analysis-of-paired-skin-and-blood-samples-from-patients-with-sle-and-cutaneous-lupus-suggests-cd16-dcs-arise-from-non-classical-monocytes-that-enter-nonlesional-skin-undergo-type-i-ifn-e/. Accessed February 1, 2023.
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/single-cell-analysis-of-paired-skin-and-blood-samples-from-patients-with-sle-and-cutaneous-lupus-suggests-cd16-dcs-arise-from-non-classical-monocytes-that-enter-nonlesional-skin-undergo-type-i-ifn-e/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences